In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols Babesia test for samples received on April 20, 2020 at the Charlotte, Dallas, Phoenix, St. Louis and Tampa laboratories. Be watching for details on an upcoming webinar that will provide you with an overview of implementing this testing.
Check out the Communication page for the complete details by clicking the link: Communications
Reminder - Dr. Buff Mair is the new CTS Medical Director. Several of the CTS client forms specify li...
As the US coast prepares for Hurricane Florence to make landfall, we have received importan...
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...
CTS communications distributed on July 6th and July 20th.In working with Grifols on the availability...
Through communications with our clients, CTS is aware of the current national blood shortage. We rea...
CTS was recently notified that one of the tubes listed in the Sample Acceptability document...